Page 61 - #03 Health Today Magazine
P. 61
Πηγές
1. Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with
overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183.
2. De Barra C, Khalil M, Mat A, et al. Glucagon‐like peptide‐1 therapy in people with obesity restores natural killer
cell metabolism and effector function. Obesity. 2023:oby.23772. doi: 10.1002/oby.23772.
3. Tadarro L Richardson Jr, Alese E Halvorson, el al. Primary Occurrence of Cardiovascular Events After Adding
Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With
Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes. Ann Intern Med. 2023 May 9. doi:
10.7326/M22-2751.
4. A&S Chemistry Professor Presents New Research on Anti-Obesity Drug. https://thecollege.syr.edu/.
60 Health Today . IOΥNIOΣ 2023 IOΥNIOΣ 2023 . Health Today 61
